
    
      The purpose of this study is to determine whether genomic effects or peripheral lymphatic
      biomarkers on antidepressant response differed by class of drug, whether genomic and
      biomarker differences between drug responders and nonresponders predict the response of
      antidepressant and to construct the prediction model for antidepressant treatment in order to
      aid to select the their genetically or endophenotypic matching drugs.
    
  